Key result
Biatrial maze improves 12-month freedom from atrial tachyarrhythmias by an absolute ~11% vs LA maze.
Why the study?
Does biatrial maze ablation improve freedom from atrial tachyarrhythmias compared to left atrial maze ablation in patients with persistent or long-standing persistent atrial fibrillation undergoing rheumatic mitral valve surgery?
RCT (n=323)
Single-blind
1:1 ratio
Yes
Does biatrial maze ablation improve freedom from atrial tachyarrhythmias compared to left atrial maze ablation in patients with persistent or long-standing persistent atrial fibrillation undergoing rheumatic mitral valve surgery?
Biatrial maze ablation during rheumatic mitral valve surgery provides superior freedom from recurrent atrial tachyarrhythmias at 12 months compared to left atrial maze ablation, without a significant increase in permanent pacemaker implantation.
Answers are grounded in this paper and cite their sources.
Supports preferring biatrial over left atrial maze in rheumatic mitral valve surgery; extends randomized evidence on ablation extent in persistent AF.
BACKGROUND: Guidelines recommend concomitant surgical ablation during cardiac surgery in patients with atrial fibrillation (AF). However, the optimal lesion set remains uncertain, with ongoing debate regarding the relative benefits and risks of biatrial versus left atrial (LA) maze ablation. METHODS: In this multicenter, randomized, single-blind trial, patients with persistent or long-standing persistent AF undergoing rheumatic mitral valve surgery, with or without concomitant cardiac surgical procedures, were randomly assigned in a 1:1 ratio to undergo biatrial or LA maze ablation. The biatrial group underwent a complete Cox-Maze IV procedure; the LA group received a left-sided maze lesion set. To ensure standardization and consistency of the ablation procedures, surgeons underwent pretrial training and certification, and all procedures were videorecorded and centrally reviewed. The primary outcome was freedom from atrial tachyarrhythmias lasting >30 seconds without antiarrhythmic drugs within 12 months. The key secondary end point was freedom from permanent pacemaker implantation. RESULTS: All 323 randomized patients were included in the intention-to-treat analysis (mean age, 56.5 years; 72.1% women; mean LA diameter, 51.9 mm). At 12 months, 78.7% of patients (129 of 164) in the biatrial group and 68.6% (109 of 159) in the LA group were free from atrial tachyarrhythmias (adjusted difference, 10.7% [1-sided lower 95% CI, 3%]; P =0.01). Freedom from permanent pacemaker implantation was noted in 97.0% (159 of 164) of the biatrial group and 98.1% (156 of 159) of the LA group, meeting the predefined noninferiority criterion with a margin of −5% (adjusted difference, –1.1% [1-sided lower 95% CI, –3.9%]; P noninferiority =0.01). CONCLUSIONS: Among patients with persistent or long-standing persistent AF undergoing rheumatic cardiac valve surgery, biatrial maze ablation was superior to LA maze ablation in reducing recurrent atrial tachyarrhythmias, while maintaining noninferiority with respect to permanent pacemaker implantation. These findings provide direct evidence to inform lesion-set selection for surgical ablation during cardiac surgery. REGISTRATION: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT05021601.
No takes yet. Share an insight, caveat, or question.
Li et al. (2026) conducted an RCT in Persistent or long-standing persistent atrial fibrillation undergoing rheumatic mitral valve surgery (n=323). Biatrial maze ablation (complete Cox-Maze IV procedure) vs. Left atrial (LA) maze ablation (left-sided maze lesion set) was evaluated on Freedom from atrial tachyarrhythmias lasting >30 seconds without antiarrhythmic drugs within 12 months (Adjusted difference 10.7%, 95% CI 1-sided lower 95% CI, 3%, p=0.01). Biatrial maze ablation was superior to LA maze ablation for 12-month freedom from atrial tachyarrhythmias.
Synapse has enriched 10 related papers. Consider them for comparative context: